Shi-Yan Ren, Yi-Zhou Zhang. Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions. // Breast Cancer. – 2025. – DOI: 10.1007/s12282-025-01727-1. – URL: https://doi.org/10.1007/s12282-025-01727-1
Shi-Yan Ren & Yi-Zhou Zhang (2025). Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions. Breast Cancer. https://doi.org/10.1007/s12282-025-01727-1
Shi-Yan Ren and Yi-Zhou Zhang. “Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions.” Breast Cancer, 2025. doi:10.1007/s12282-025-01727-1.
@article{Ren2025,
title = {Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions},
author = {Ren, Shi-Yan and Zhang, Yi-Zhou},
journal = {Breast Cancer},
year = {2025},
doi = {10.1007/s12282-025-01727-1},
url = {https://doi.org/10.1007/s12282-025-01727-1}
}